People who are living with diabetes often experience damage to their retinas, an eye disease known as diabetic retinopathy. According to the U.S. Food and Drug Administration, diabetic retinopathy is the most common cause of vision loss among people with diabetes and is the number one cause of vision problems among working-age adults. The FDA recently approved the IDx-DR program, which utilizes artificial intelligence (AI) to detect diabetic retinopathy.

"Early detection of retinopathy is an important part of managing care for the millions of people with diabetes, yet many patients with diabetes are not adequately screened for diabetic retinopathy since about 50 percent of them do not see their eye doctor on a yearly basis," said Dr. Malvina Eydelman, director of the FDA's Division of Ophthalmic, and Ear, Nose and Throat Devices.

If you are living with diabetic eye disease, we invite you to learn more about our programs.

“FDA Approves AI Device to Spot Diabetic Eye Disease”